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CHARACTERIZATION OF FAM65B KNOCK-OUT MICE AND ROLE OF 
FAM65B IN SKELETAL MUSCLE STEM CELLS DIFFERENTIATION 
ALESSANDRO COLLETTA 
ABSTRACT 
The family with sequence similarity 65, member B (Fam65b) protein is thought to 
facilitate fusion of myocytes and formation of myotubes during the differentiation of 
human myogenic cells. Fam65b and histone deacetylase 6 (HDAC6) co-
immunoprecipitate and together regulate the levels of acetylated tubulin, which might 
control microtubule stability in myogenic cells. In this thesis, to gain further insight on 
the role of Fam65b in the differentiation pathway and motility of myogenic cells, we 
characterized a Fam65b knock-out (KO) mouse model. Genotyping and transcriptional 
analysis revealed that a thirteen exons-long region of the Fam65b gene has been 
successfully ablated and the mRNA amplicons within the deleted segment are not 
transcribed. Nevertheless, mRNA products corresponding to genomic regions 
downstream of the deleted area are still detected. Furthermore, analysis of skeletal muscle 
lysates via western blot (WB) does not show a complete loss of Fam65b expression, but 
only reduced translation of some isoforms. Nevertheless, WBs of myogenic cells that 
have been directly isolated from Fam65b KO mice and expanded in vitro revealed the 
absence of a 120 Kd band, which putatively corresponds to the long isoform of Fam65b. 
Finally, our data show that Fam65b KO mice are significantly heavier than wild type 
(WT) mice, and that this phenotype is consistently observed across both genders during 
the first seven months of age. While functional and molecular analyses of the KO mouse 
  vi 
model are still ongoing, future work might include generating a new KO model via the 
CRISPR-Cas9 technology to ablate all isoforms of Fam65b. 
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INTRODUCTION 
Skeletal muscle is a striated tissue principally composed of multinucleated 
syncytial cells named myofibers. As it accounts for about 35 to 40% of human body 
weight, it represents the most abundant tissue in our body. Skeletal muscles allow for the 
accomplishment of vital functions such as locomotion, physical support, breathing and 
thermogenesis. Unlike smooth and cardiac muscle tissues, skeletal muscle cells are 
directly innervated by the somatic nervous system, which allows for voluntary 
contraction (Boron & Boulpaep, 2012). One distinguishing feature of skeletal muscle lies 
in its ability to adapt to the environment, which can be observed under a multitude of 
physiological and disease-like states. Indeed, while endurance training may lead to 
muscle hypertrophy and enhanced strength, other conditions, like cancer, chronic 
obstructive pulmonary disease and denervation, can induce atrophy and loss of function. 
In addition to this remarkable adaptive potential, skeletal muscle exhibits great 
regenerative capacity. In fact, few weeks after a major traumatic event, skeletal muscle 
structure and function can be restored. This property is due to the activity of skeletal 
muscle stem cells, named satellite cells (Mauro, 1961). The capacity of this cell 
population to re-enter the cell cycle, differentiate and fuse to form regenerating myofibers 
allows for the maintenance of homeostasis of skeletal muscle tissue (Dumont et al., 
2015). 
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Figure 1. Representation of skeletal muscle myofibers and satellite stem cells. Adapted 
from Bentzinger, Wang, & Rudnicki, 2012. 
 
Skeletal Myogenesis  
The generation of muscle tissue - myogenesis - can be mainly organized into 
embryonic and adult phases. During embryonic development, muscle founder stem cells, 
which are located in the dorsal somites of the paraxial mesoderm, give rise to the 
dermomyotome (DM), the first site where commitment to myogenesis occurs 
(Buckingham et al., 2003; Sambasivan & Tajbakhsh, 2007; Endo, 2015). These stem 
cells are marked by the expression of the transcription factors paired box 3 (Pax3) and 
paired box 7 (Pax7) and low expression of the basic helix–loop–helix (BHLH) 
transcription factor myogenic factor 5 (Myf5) (Jostes, Walther, & Gruss, 1990; Goulding 
et al., 1991; Kiefer & Hauschka, 2001). At this developmental stage, the progenitor cells 
of the DM, undergo an epithelial to mesenchymal transition, migrate underneath the DM 
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and differentiate into mononucleated myocytes to form the myotome. These mononuclear 
precursor cells, known as myoblasts, express high levels of Myf5 and myoblast 
differentiation protein (MyoD) and are marked for terminal differentiation to the muscle 
lineage.  Myf5 and MyoD are two myogenic regulatory factors (MRFs) and both belong 
to the basic helix loop helix (bHLH) transcription factor family (Pownall, Gustafsson, & 
Emerson, 2002; Francetic & Li, 2011). Myoblasts first fuse together in a process referred 
to as “primary fusion” and give rise to nascent myotubes, which are very long, 
plurinucleated syncytia. During a second phase, additional myoblasts unite with nascent 
myotubes, a step known as “secondary fusion” (Buckingham, 2001). This process results 
in the growth of myotubes, myonuclear accretion and the subsequent formation of 
myofibers, which are the multinucleated contractile cells typical of adult skeletal muscle 
(Hindi, Tajrishi, & Kumar, 2013; Yin, Price, & Rudnicki, 2013).   
Myofibers are post mitotic, arrested in the G0 phase of the cell cycle and unable 
to proliferate. They have a longitudinal, cylindrical shape and are internally constituted of 
myofibrils, which contain myosin and actin filaments that allow for muscular 
contractions. These myofibers are compounded into bundles by a complex and structured 
network of extracellular matrix (ECM), specifically, the endomysium and the basement 
membrane. The endomysium represents the most external membrane, made primarily of 
collagen fibers and interlaced with a network of nerve fibers and blood vessels. The 
basement membrane, located between the endomysium and the myofiber membrane 
(plasmalemma), can be further subdivided into the basal lamina and the reticular lamina 
(Dumont et al., 2015; Boron & Boulpaep, 2012).  
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Unlike the de novo embryonic generation of muscle tissue described above, adult 
myogenesis is dependent upon the retention of the ECM scaffold, where a specific 
population of quiescent stem cells resides (Le Grand & Rudnicki, 2007). These 
progenitor cells, which originate from the central portion of the dermomyotome early in 
embryogenesis, and later, during fetal development, position themselves between the 
plasmalemma and the basal lamina and are marked by the constitutive expression of the 
transcription factor Pax7 (Seale et al., 2000; Gros et al., 2005). Following activation, 
which may be induced by either stress, trauma, or microenvironment-secreted growth 
factors, satellite cells move outside of the basal lamina, re-enter the cell cycle and co-
express the transcription factors Pax7, Myf5, MyoD. Then, these activated satellite cells, 
also known as cycling myoblasts, differentiate into myocytes by downregulating Pax7 
expression while maintaining elevated levels of MyoD and by upregulating two other 
MRFs, MRF4 and myogenin. Finally, downregulation of MyoD and prolonged 
expression of both MRF4 and myogenin induce myocytes to either fuse homotypically to 
form nascent multinucleated myotubes or to fuse with regenerating myofiber end-
fragments (Dumont et al., 2015).  
It should be noted that a stochastic mode of symmetric cell division into a more 
committed cell type would result in depletion of the satellite stem cell pool 
aforementioned. Instead, satellite cells utilize asymmetric division to self-renew and 
generate another cell that is identical to the original stem cell in addition to a committed 
daughter cell that will commit to myogenic differentiation. This process allows for self-
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maintenance of the satellite cell pool and, at the same time, creates a more committed 
myogenic progeny (Shinin et al., 2006; Kuang et al., 2007). 
 
 
Figure 2. Schematic of adult myogenesis. The process of adult myogenesis and the temporal 
expression of critical transcription factors are illustrated. Adapted from Le Grand & Rudnicki, 
2007. 
 
Myogenic Differentiation in vitro 
The maintenance of murine and human myoblasts in vitro is an essential 
technique for studying the differentiation pathways of myogenic progenitors, the 
characterization of muscle disorders and the potential development of cell-based 
therapies. In vitro culturing of C2C12 cells, an immortalized murine myoblast cell line 
that was originally isolated by Yaffe D. in 1977, is often utilized to study mammalian 
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skeletal myogenesis due to its ease of culture, differentiation potential and accessibility 
(Yaffe & Saxel, 1977; Nag & Foster, 1981; Burattini et al., 2004).  Conversely, pure 
cultures of primary human myoblasts are more difficult to obtain because of the presence 
of non-myogenic mononuclear cells in human skeletal muscle, like adipocytes, 
fibroblasts and lymphocytes (Malatesta et al., 2013). In order to specifically enrich for 
myoblasts within a dissociated human muscle sample, fluorescence-activated cell sorting 
(FACS) is used to select cells expressing human neural cell adhesion molecule (NCAM), 
also known as cluster of differentiation (CD) 56 (Webster et al., 1988); indeed, this cell 
surface molecule was discovered to be highly expressed on myogenic cells (Walsh & 
Ritter, 1981). Myogenic cells derived from human skeletal muscle can be purified by 
positive selection for CD56 expression and negative selection of CD34 (CD56+ CD34- 
cells), which select for myogenic but non-adipogenic precursors in human skeletal 
muscle (Pisani et al., 2010).  Recently, melanoma cell adhesion molecule (MCAM), an 
antigen expressed in mononuclear proliferating myoblasts, but significantly 
downregulated during fusion, has been utilized to selectively purify myogenic from 
dissociated human fetal skeletal muscle (Cerletti et al., 2006; Lapan & Gussoni, 2012).  
MCAM, however, does not select for adult human myoblasts.  Primary cultures of murine 
myoblasts can be obtained from dissociated mouse muscle tissue following purification 
of satellite cells by FACS. In 2001, cells isolated from hindlimb muscles of neonatal mice 
containing a mixture of myoblasts, fibroblasts and other cell types were enriched for a 
purified myoblast population by selecting for a7 integrin (ITGA7) expression (Blanco-
Bose et al., 2001). Optimization of murine skeletal myogenic progenitors (SMPs) was 
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subsequently achieved via FACS purification using CD34 and ITGA7 as positive 
selection markers, while CD31, CD45 and CD11b were utilized as negative selection 
markers (Sacco et al., 2008; Bareja et al., 2014). 
Several factors affect the switch from the proliferation to the differentiation state 
of both murine and human skeletal myoblasts; this process is characterized by cell cycle 
exit and the formation of multinucleated myotubes. In vitro, myoblasts can be expanded 
in the presence of high serum concentrations (10 to 20% fetal calf serum) and by 
supplementing mitogenic growth factors, such as basic fibroblast growth factor (bFGF) 
(Sheehan & Allen, 1999). Undifferentiated cells are about 20-80 µm in size, look flat, not 
confluent, and are closely adherent to their substrate; they appear star-shaped or fusiform, 
possess one central nucleus with numerous nucleoli, and are characterized by the 
presence mitotic figures. Differentiation and fusion of neighboring myonuclear cells is 
triggered by switching the culture to low serum medium (1-4% fetal calf or horse serum) 
and the withdrawal of mitogens. As myoblasts begin their process of differentiation, they 
acquire a mainly elongated shape, and intercellular spaces progressively recede. 
Myotubes become evident after 36 to 48 hours in differentiation medium, and 
progressively continue to grow in size. At this time point, they are multinucleated and 
frequently elongated in three to four directions. Transmission electron microscope (TEM) 
analysis reveals that, within the cytoplasm, thin and thick filaments both organize to form 
sarcomeres and myofibrils, and these structures appear to be similar to those present in 
adult skeletal muscle (Burattini et al., 2004). However, mature myotubes only appear 5 
days post addition of differentiation medium (Curci et al., 2008).  
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Figure 3. Murine myogenic cells in proliferation and differentiation medium. Figure 3A 
illustrates proliferating mononuclear cells (myoblasts) in high serum DMEM medium, 
supplemented with bFGF. Figure 3B illustrates myogenic cells at 48 hours post addition of 
differentiation medium; at this time-point myotubes form and elongate in multiple directions. 
 
Distinct signaling pathways regulate myogenic progression and subsequent 
differentiation in vitro. Downregulation of Pax7 transcription via the action of specific 
microRNAs and increased expression of MyoD due to mitogen-activated protein kinase 
(MAPK) signaling protein p38α play a pivotal role in the transition from myoblast 
proliferation to differentiation (Lluís et al., 2005). MyoD initiates differentiation by 
inducing cell cycle inhibitors like p21,while upregulation of myogenin and MRF4 has a 
critical role in late differentiation (Halevy et al., 1995; Rawls et al., 1998). Indeed, 
MyoD-/- myoblasts fail to upregulate MRF 4 and myogenin, thus displaying 
differentiation defects and impaired muscle regeneration (Cornelison et al., 2000).  
Following induction of the differentiation program, myoblasts undergo cell fusion 
which results in the formation of myotubes. Numerous proteins involved in cell-cell 
adhesion and actin dynamics have been implicated in syncytial fusion (Charrasse, 2002; 
Charrasse et al., 2007). Myomarker is the only muscle specific membrane protein 
A. B. 
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identified so far that is both necessary and sufficient to induce the plasma membrane of 
myoblasts to fuse in vivo and in vitro. It should be noted that while ablation of 
myomarker prevents the formation of multinucleated myotubes and myofibers, it does not 
affect MyoD and myogenin expression levels (Millay et al., 2013), implying that 
expression of myomarker is downstream of MyoD and myogenin.  
The role of Fam65b in skeletal myogenic differentiation 
With the scope of discovering new genes involved in the differentiation and 
fusion of human skeletal muscle cells, microarray analyses of primary fetal myoblasts 
were conducted to identify differentially expressed genes during myogenic 
differentiation. Among others, the transcription levels of Family with sequence similarity 
(Fam65b), also known as C6orf32 and pl48, was highly elevated during early myogenic 
differentiation, specifically when myotubes had up to 5 nuclei. Fam65b expression levels 
were up to16 times greater than in mononuclear cells until myotubes reached a size up to 
15 nuclei (Cerletti et al., 2006). Expression of Fam65b protein was confirmed during 
early fusion of human fetal myoblasts and its polar localization within the cells (Yoon et 
al., 2007). It appeared that Fam65B was mainly located within the cell cytoplasm, in 
proximity of the plasma membrane. This protein seemed to be associated with the cell 
cytoskeleton and localized to one side of the cell, leading us to hypothesize that Fam65b 
may have a function in cell polarity (Yoon et al., 2007). mRNA knock-down of Fam65b 
using small interfering RNAs (siRNAs) using oligonucleotides in C2C12 myoblasts 
showed that cell fusion and expression of myosin heavy chain (MHC), a marker of 
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medium-late myogenic differentiation, were significantly compromised. While the 
expression of MyoD, the master regulator of skeletal myogenic differentiation in 
proliferating myoblast, was not altered, the expression of myogenin, a differentiation 
marker downstream of MyoD, was significantly reduced (Yoon et al., 2007). These 
findings indicated a role for Fam65b during myogenic differentiation at a stage between 
MyoD and myogenin expression. Overexpression of Fam65B in C2C12 cells leads to the 
formation of significantly longer filopodia-like structures relative to control cells. 
Furthermore, in-frame deletion constructs of Fam65B identify that the N terminal region 
(55aa-113aa) is important for protrusion formation, suggesting a role in cytoskeletal 
rearrangement and possible cell motility. 
Fam65B putatively encodes for 12 alternatively spliced polypeptides and WB 
analysis of lysates of human fetal myoblast found two major isoform of Fam65B: one of 
105Kd (1018 aa) and one of 70Kd (591 aa). Both these isoforms contain an extremely 
conserved protein domain in the N-terminus of the protein (aa 79-116) that has 
similarities to a putative HDAC-binding site. To address if Fam65b is a an HDAC-
binding protein, immunoprecipitation experiments were conducted and Fam65B was 
found to bind histone deacetylase 6 (HDAC6) (Balasubramanian et al., 2014). As the 
literature reports, HDAC6 is a cytoplasmic HDAC that regulates microtubule dynamics 
via deacetylation of α-tubulin ( Y. Zhang et al., 2003; X. Zhang et al., 2007). Increased 
expression of Fam65B at 1 day following differentiation resulted in a decrease in 
HDAC6 de-acetylating activity, which was followed by an increase in the levels of 
acetylated tubulin and myogenin expression (Balasubramanian et al., 2014). These results 
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suggest that Fam65B, by binding HDAC6, prevents this protein from deacetylating 
tubulin. As increased levels of acetylated tubulin lead to increased microtubule stability 
and increased expression of myogenin, it may further explain why overexpression of 
Fam65B leads to a significantly greater number of cell protrusions (Yoon et al., 2007; 
Conacci-Sorrell, Ngouenet, & Eisenman, 2010). Silencing of HDAC6 RNA expression in 
human primary myogenic cells resulted in tubulin hyperacetylation (Balasubramanian et 
al., 2014). As high levels of acetylated tubulin were detected, the cells responded via a 
mechanism of negative feedback and downregulated expression levels of Fam65B and 
myogenin, which consequently led to impaired myogenic differentiation. This result was 
further supported by the fact that prolonged treatment of human myoblasts with HDAC6 
inhibitors, as also indicated by other studies, prevented rather than favored skeletal 
muscle differentiation ( Nebbioso et al., 2009; Balasubramanian et al., 2014). 
The Role of Fam65B in other cell types 
Recently, the function of Fam65b has also been investigated in non-myogenic 
cells and results showed that its role may be pivotal to both hearing and immune 
competence (Pablo Rougerie et al., 2013; Diaz-Horta et al., 2014; Gao et al., 2015). 
Studies have indeed shown that Fam65B associates with the plasma membrane of hair 
cells and lack or reduced expression of this protein can impair the mechanotransduction 
processes in the inner ear. Indeed, mutations leading to exon skipping in humans as well 
as Fam65b mRNA silencing in zebrafish are responsible for hearing loss (Diaz-Horta et 
al., 2014). Instead, experiments on neutrophils and Jurkat cells, an immortalized line of 
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human T lymphocyte cells, showed that Fam65B binds to Ras Homolog Gene Family 
Member A (RhoA) and plays a role in the regulation of cell migration and polarization 
(P. Rougerie et al., 2013; Gao et al., 2015). Although both studies showed that Fam65B 
negatively regulates the activity of RhoA by inhibiting the loading of GTP onto RhoA, 
different conclusions were drawn in regard to the role of Fam65B in relation to cell 
polarity and migration. Indeed, Rougerie et al. (2013) showed that Fam65B negatively 
regulates cell migration and polarity in T cells. Yet, Gao et al. (2015) demonstrated that 
the same protein polarizes at the leading edge of neutrophils, and that contributes to 
localize RhoA and phosphorylated myosin light chain (pMLC) to the back of the cells; 
furthermore, this study reported that neutrophils of Fam65B KO mice showed impaired 
directionality during chemotaxis and impaired migration toward areas where 
inflammation had been induced. Consequently, it remains important to elucidate which 
role Fam65B may play in cell motility, polarity and regulation of RhoA activity within 
differentiating skeletal myoblasts. As our lab has generated a Fam65B knock-out mouse 
model, comparison of aforementioned parameters between wild type (WT) and knock-out 
tissues will improve the validity of our analysis. 
Aim and Objectives 
In this thesis, we generated a mouse KO model to allow us to better analyze the 
function of Fam65b in the differentiation of myogenic cells in vivo.  Fam65B knock-out 
mice were characterized at the gene, transcript and protein levels.  We conducted 
polymerase chain reaction (PCR), Reverse Transcriptase (RT)-PCR and WB experiments 
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on mouse skeletal muscle tissues and primary myogenic cells extracted from the same 
animals. To investigate whether loss of Fam65b expression compromises the 
regeneration of skeletal muscles and muscle stem cell activity, the tibialis anterior (TA) 
muscles of both WT and KO mice were injured by injection of cardiotoxin (CTX). 
Muscles were harvested seven days after inducing the injury, sectioned and stained by 
Hematoxylin and Eosin to determine if muscle regeneration was occurring properly.  
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 METHODS 
Genotyping 
Genomic DNA was extracted from tails of KO and WT mice as described by 
Zangala (2007). The isolated DNA was then amplified by PCR. Primer set 1 and 4 were 
used for amplifying WT DNA. The sequences were as follows: primer set 1, 
TTAGGCTTAGGAGCCTGTG (SUF, forward) and 
GGAAGGAGTCTGCAACTAACTGTG (TUR, reverse); primer set 4, 
AAGGGTTCAACCCAGTCTAAGG (TDF, forward) and 
GTCTCTGCTACCAAGTGACAAAGTGC (Fam1R, reverse) SUF, TUR and TDF 
primers were recommended by the KOMP repository that generated the ES KO cell line. 
Primer set 2 and 3 were utilized to amplify the DNA of KO mice. The sequences were as 
follows: primer set 2, TTAGGCTTAGGAGCCTGTG (SUF, forward) and 
GTCTGTCCTAGCTTCCTCACTG (LacZRev, reverse); primer set 3, 
TTCGGCTATGACTGGGCACAACAG (NeoF, forward) and 
GTCTCTGCTACCAAGTGACAAAGTGC (Fam1R, reverse). 
Touchdown PCR was performed using equal amount of DNA (1 µg), 0.5 mM  
each of forward and reverse primer. Reactions run with primers 1, 4, and 3 were 
amplified in 2 phases. In phase I, the polymerase was activated for 3 min at 95°C, 
followed by denaturation at 95°C for 10s, successively lower annealing temperatures 
(Tm) between  65°C  and 55°C (i.e., decreasing the Tm of the reaction 1°C/cycle) for 30s, 
followed by extension at 72°C for 20s over the course of 10 cycles. In phase II, 
15 
  
 
denaturation was at 95°C for 10s, annealing at 55°C for 30s, followed by extension at 
72°C for 20s for 30 cycles. A final elongation step was performed at 72°C for 5 min. The 
reaction with primer set 2 was run with no touchdown methodology and the following 
conditions were followed: denaturation at 95°C for 10s, annealing at 51.5°C for 30s, and 
extension at 72°C for 20s for 40 cycles. The end product of the PCR reactions were 
electrophoresed on 1% agarose gel and DNA was visualized by ethidium bromide 
staining. 
RNA Extraction and RT-PCR 
Total RNA was isolated from mouse gastrocnemius muscle tissue. In brief, 
individual muscle samples were immersed into 1 mL of trizol and homogenized. Samples 
were transferred into separate eppendorf tubes and 200 µL of chloroform was added to 
each tube to induce a phase separation. After centrifugation (12,000g for 15 min at 4 ̊ C), 
the aqueous layer was extracted and combined with 500 µL of isopropanol to precipitate 
the RNA; the samples were then frozen at - 20 ̊ C for 1 hour. After centrifugation 
(12,000g for 10 min at 4 ̊ C), the supernatant was decanted, and 1 mL of 75% ethanol was 
added to each pellet. After a final spin (7,500g for 5 min at 4 ̊ C), the supernatant was 
decanted; the pellet of each sample was air-dried, resuspended in RNase-free water; RNA 
concentration and purity were analyzed via Nano drop. 
For reverse transcription, the SuperScript III First Strand was used according to 
the manufacturer’s instructions to reverse transcribe RNA into cDNA (Invitrogen, 
Carlsbad, CA). RT- PCR was performed with 1µg of cDNA, and 0.5 µM of each forward 
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and reverse primer. Four primer sets were employed: primer sets 4-10 and 6-10 were 
used to amplify cDNA segments between exon 4 to 10, and exon 6 to 10 of the Fam65B 
gene, respectively; primer set 20-23 amplifies a cDNA fragment between exon 20 and 23, 
while the dystrophin primer set was utilized as positive control to amplify a segment of 
cDNA between exon 8 and 10 of the Dystrophin gene. The primer sequences were as 
follows: AGAAACTCTCGCCTGGGTGT (Fam65b exon 4, forward) and 
CACCTCTGCCGACCATACTT (Fam65b exon 10A, reverse); 
GACGCCTGGAGTTTCACATT (Fam65b exon 6, forward) and 
CAGGAAGACGGTTTCTGCTC (Fam65b exon 10B, reverse); 
TGACAATGAGGTCAGCGAAG (Fam65b exon 20, forward) and 
AACTTCGGTTCCATGACGAC (Fam65b exon 23, reverse); 
ATGTTGCCCAGGACATCTTC (Dystrophin exon 8, forward) and 
CTCCTTGTGCTCGCAATGTA (Dystrophin exon 10, reverse). 
The specific conditions for the PCR reactions where primer sets Fam65b 4-10, 
Fam65b6-10 and dystrophin  were as follows: 95°C for 3 min, followed by 40 cycles of 
amplification (denaturation at 94°C for 45s, annealing at 57°C for 45s and extension at 
72°C for 45s), and a final elongation step at 72°C for 5 min. For primer set 20-23, due to 
the lower Tm of both forward and reverse primers, the only parameter to be modified 
relative to the conditions outlined above was the annealing temperature, which was set at 
54 °C. The end product of the PCR reactions were electrophoresed on 1 % agarose gel 
and DNA was visualized by ethidium bromide staining. 
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Primary human and murine muscle cell isolation and FACS analysis of MCAM+ cells.  
Mononuclear cells were isolated from either deidentified, discarded human fetal 
muscle samples or murine skeletal muscles. Collection was approved by the Committee 
of Clinical Investigation at Boston Children’s Hospital and Brigham and Women’s 
Hospital (Boston, MA). Skeletal muscle was minced and enzymatically dissociated with 
0.5 mg/ml collagenase D and 0.6 U/mL dispase II (Roche Applied Science, Indianapolis, 
IN) for 45–75 min at 37°C as previously described (Lapan & Gussoni, 2012). Cells were 
filtered through cell strainers before being stored at -150°C for later use. Human and 
murine fetal muscle cells were cultured on sterile tissue culture-treated plates (Corning, 
Corning, NY) 24 hr prior to FACS analysis. Cells were washed once with 1X Hank’s 
Balanced Salt Solution (HBSS) and lifted using cell dissociation buffer (Invitrogen 
Gibco, Grand Island, NY). Samples were filtered and resuspended in warm 0.5% 
BSA/HBSS followed by incubation with anti-MCAM antibody conjugated with Alexa 
Fluor488 (Millipore, Billerica, MA) at a dilution of 1:100. Samples were washed, 
resuspended in 1g/mL propidium iodide/0.5% BSA/HBSS, and filtered through a 40 µm 
filter prior to FACS analysis and sorting. 
Cell culture of myogenic cells 
MCAM + myogenic cells were cultured in growth medium (DMEM-high glucose, 
20% fetal bovine serum, 100 U/mL penicillin, and 100g/mL streptomycin). At 80% 
confluence, myogenic cells were induced to differentiate in DMEM-low glucose, 2% 
horse serum, 100 U/mL penicillin, and 100g/mL streptomycin. Differentiation medium 
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was changed every day, and cells were monitored for myotube formation. Proliferating 
cells in growth medium with high glucose and serum were harvested and name 
“undifferentiated” samples, whereas the differentiating cells were harvested post the 
addition of DMEM-low glucose medium and labeled as “24hr” and “48hr” samples. 
 
Protein lysates preparation and Western blot analysis. 
 
Cell lysates were prepared by adding mammalian protein extraction reagent (M-
PER) (Thermo Scientific, Pittsburgh, PA) containing protease inhibitors (Roche Applied 
Sciences, Indianapolis, IN) to cells that had been harvested. Cells were then spun at 
13,200 rpm for 20 min at 4°C, and the supernatant was collected and stored at -80°C for 
WB analysis. Lysates derived from murine whole muscles were prepared by initially 
grinding the tissue with sterile mortar and pestle. Tissues were then transferred into 
Lysing Matrix D tubes (MP Biomedicals, Santa Ana, CA), resuspended with 400 μL of 
M-PER/protease inhibitor cocktail, and homogenized 3 to 4 times via 30s cycles. The 
samples were finally centrifuged at 12,000 rpm for 10 min at 4 °C, and the supernatant 
was stored at -80 °C until use. Protein lysates were quantified using the Pierce BCA 
Protein Assay (Thermo Scientific, Pittsburgh, PA, USA) to ensure equal amount of 
loading for each samples. For WB analyses, 15 μg of total protein lysates were diluted 
with 2X sample loading buffer, heated for 3 min at 80°C and spun at 13,200 rpm, at 4°C 
for 2 min. Proteins were then separated using Precast NuPage 4 –12% Bis/Tris 
acrylamide gel (Invitrogen, Carlsbad, CA) SDS-PAGE.  The proteins were wet-
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transferred by using 0.45 μm pore size PVDF membranes (Invitrogen, Carlsbad, CA). 
Blocking of non-specific binding was performed with either 3% BSA or 5% BSA and 1% 
nonfat dry milk in 1 X TBS Tween (0.1%) for 60 min. Membranes were incubated in 
primary antibody diluted at 1:1000 in blocking solution overnight at 4°C. Blots were 
washed with 1 X TBS Tween (0.1%) and incubated with HRP-conjugated secondary 
antibody diluted at 1:2000 in blocking solution; then were washed in 1X TBS Tween 
(0.1%) and developed using ECL solution (Perkin Elmer, Waltham, MA). The primary 
antibodies used were hC6ORF32-M01 (1:1000; Novus Biologicals, Littleton, CO) 
Fam65B custom made (1:1000) and GAPDH (1:5000; Santa Cruz Biotechnology, Dallas, 
Texas). Secondary antibodies used were donkey anti-rabbit IgG HRP (1:10000; Jackson 
ImmunoResearch Laboratories, West Grove, PA) and goat anti-mouse IgG HRP 
(1:10000; Jackson ImmunoResearch Laboratories, West Grove, PA). 
Animal Husbandry 
WT C57Bl/6 mice and Fam65b-/-, which had been generated in the C57Bl6 background, 
were housed and handled in compliance with the guidelines of the Boston Children's 
Hospital committee for animal research. All experimental procedures were performed as 
described in the protocol approved by the Boston Children's Hospital Institutional Animal 
Care and Use Committee. The weights of KO and WT mice were also recorded monthly 
for a period of 15 months. Mice were euthanized at the age of 15 months. Quadriceps, 
gastrocnemius, triceps were utilized for RNA and protein analysis, while tails were used 
for DNA extraction. Tibialis Anterior muscles of both KO and WT mice were subject to 
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injury by injection of CTX (20 μL of 0.5 μg/μL stock) from Naja mossambica (Sigma-
Aldrich, Natick, MA). Muscles were harvested 7 days after CTX injection , and were 
frozen for histological examination exactly as described by Meng et al. (2014).  
  
21 
  
 
RESULTS 
Fam65B location within the Mus musculus genome is chromosome 13: 
24,674,058-24,825,685. It is reported that 6 alternatively spliced transcripts are known to 
be protein coding: Fam65b-002 (633 aa, 14 exons), Fam65b-003 (1078 aa, 23 exons), 
Fam65b-006 (1053 aa, 23 exons), Fam65b-007 (672 aa, 15 exons), Fam65b-201 (1034 
aa, 22 exons), Fam65b-202 (583 aa, 14 exons) (“Ensembl genome browser 54: 
M.musculus - Gene summary - Gene: Fam65b (ENSMUSG00000036006),” n.d.) (Figure 
4). WB analysis of lysates human fetal myoblasts revealed that two major isoforms were 
expressed during myogenic differentiation: one being 1018 aa (105 Kd) and the other one 
being 591 aa (72 Kd) (Yoon et al., 2007). 
 
 
 
Figure 4. Fam65B protein coding transcripts in Mus musculus. Six alternatively spliced 
transcript for the Fam65B gene are reported to be coding for protein. Adapted from Archive 
Ensemble Release 37. 
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Description of Fam65B Deletion Cassette. 
Fam65b -/- mice were generated from the knock-out mouse project (KOMP) by 
using the Embryonic Stem Cell (ECS) clone 15686A-B6, in which exons 2-14 have been 
deleted. Therefore, the genomic regions coding for exon 1 and exons 15-23 remain part 
of the mice DNA. The deleted genomic sequence is 34,926 bp long. The deleted region 
was substituted via homologous recombination with a bacterial artificial chromosome 
(BAC) vector which contains both a B-galactosidase and a neomycin coding sequences 
(Velocigene, KOMP, Davis, CA). Figure 5 shows a representation of the deletion map. 
  
Figure 5. Deletion strategy for Fam65B -/- ECS clone 15686A-B6. A map of the deletion 
cassette employed to delete portion of the Fam65B gene, spanning a region from the beginning 
of exon 2 to the end of exon 14. The BAC vector replacing the deleted area contains both a 
reporter and a selection cassette. Adapted from Velocigene, KOMP. 
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Genomic analysis of Fam65b-/- mice. 
To characterize the Fam65b-/- mice and verify the gene deletion, we performed 
PCR analysis of genomic DNA extracted from the tails of 12 Fam65-/- mice. It should be 
noted that reactions 1 and 4 only amplify WT genomic DNA, while reactions 2 and 3 
only amplify genomic DNA within the BAC deletion vector. Figure 6 is a diagram 
showing the adopted genotyping strategy and Table 1 lists the primers utilized for each 
individual PCR reaction and the size of the expected amplicon. Finally, images of the 
gels run for each PCR reaction are shown in Figures 7-10. 
 
 
Figure 6. Genotyping strategy for Fam65b-/- and WT mice. The diagram shows how primers 
have been designed to amplify genomic amplicons which are either present with the DNA of WT 
mice or part of the BAC vector inserted into Fam65b-/- mice. Adapted from Velocigene, KOMP. 
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  Forward Primer Reverse Primer Length WT HET KO 
Reaction 1 SUF TuR 1030 bp + + - 
Reaction 2 SUF LacZR 320 bp - + + 
Reaction 3 NeoF Fam1R 698 bp - + + 
Reaction 4 TDF Fam1R 1545 bp + + - 
 
Table 1. PCR conditions for genotyping of WT and Fam65b-/- mice. A list of the primers 
utilized for specific PCR reactions and the size of the expected amplicons is provided. The 
genetic background where we expect to observe specific PCR products is also reported. 
 
 
Figure 7. PCR reaction 1. The expected amplicon product of this reaction is 1030 bp. This 
amplicon is only amplified from DNA of a WT mouse and the heterozygous AF9 cell line. This 
amplicon is not amplified from DNA of Fam65b-/- mice. 
 
 
 
 
 
 
100bp 
ladder 
H2O  WT AF9 +/- KO-1 KO-2 KO-3 KO-4 KO-5 KO-6 KO-7 KO-8 KO-9 KO-10 KO-11 KO-12 100bp 
ladder 
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Figure 8. PCR Reaction 2. The expected amplicon product of this reaction is 320 bp. This 
amplicon is only amplified from DNA of Fam65b-/- mice, the Fam65b-/- AB6 cell line and the 
heterozygous AF9 cell line. This amplicon is not amplified from DNA of a WT mouse. 
 
 
 
Figure 9. PCR Reaction 3 and 4. The expected amplicon product of reaction 3 is 698bp; this 
amplicon is only amplified from DNA of Fam65b-/- mice and the heterozygous AF9 cell line. The 
expected amplicon product of reaction 4 is 1545bp and should be amplified only from the DNA of 
the WT mouse and of the heterozygous AF9 cell line. As reactions 3 and 4 utilize fwd and rev 
primers with similar Tm, they were run simultaneously. 
H2O  WT AB6 -/- KO-1 KO-2 KO-3 KO-4 KO-5 KO-6 KO-7 KO-8 KO-9 KO-10 KO-11 KO-12 100bp 
ladder 
AF9 +/- 
100bp 
ladder 
H2O  WT AF9 +/- KO-1 KO-2 KO-3 KO-4 KO-5 KO-6 KO-7 KO-8 KO-9 KO-10 KO-11 KO-12 100bp 
ladder 
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Figure 10. PCR Reaction 4. The expected amplicon product of reaction 4 is 1545bp and is only 
amplified only from the DNA of the WT mouse and of the heterozygous AF9 cell line. 
 
The results of this genomic analysis show that Fam65b-/- mice lack the region of 
the gene that has been replaced with the BAC vector. Reaction 1 employs a forward 
(fwd) primer upstream of the deleted region and a reverse (rev) primer that is within the 
region deleted in Fam65B-/- mice. As predicted, this reaction amplifies the expected 
1030bp amplicon only from WT DNA or the heterozygous AF9 cell line. Similarly, 
reaction 4, which utilizes a rev primer downstream of the deleted region and a fwd primer 
within the deleted region only amplifies the expected 1545bp amplicon from the DNA of 
WT animals and the heterozygous AF9 cell line. Conversely, reactions 2 and 3 use 
primers that can only anneal with DNA regions within the BAC deletion vector. As 
expected, these reactions respectively amplify a 320bp amplicon and a 698bp amplicon 
only from DNA of Fam65b-/- mice, the Fam65b-/- AB6 cell line and the heterozygous 
AF9 cell line. 
100bp 
ladder 
H2O  WT AF9 +/- KO-1 KO-2 KO-3 KO-4 KO-5 KO-6 KO-7 KO-8 KO-9 KO-10 KO-11 KO-12 100bp 
ladder 
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RNA isolation and RT-PCR analysis. 
To confirm that the Fam65-/- mouse model is also a KO at the transcriptional 
level, total RNA was isolated from the quadriceps of Fam65b-/- and WT mice and 
converted into cDNA.  RT-PCR was performed to identify the Fam65B muscle 
transcripts in both KO and WT mice. Four sets of fwd and rev cDNA primers were 
generated. Primer sets 4-10 and 6-10 respectively amplify Fam65b cDNA regions that 
span exons 4 to 10 and exons 6 to 10; consequently, as our KO model deletes genomic 
DNA from exon 2 to exon 14, these reactions should only amplify cDNA extracted from 
muscle tissue of WT mice. Instead, primer set 20-23 amplifies a Fam65b cDNA region 
that spans exons 20 to 23. As this segment is outside of the deleted area, a RT-PCR 
product could also be potentially generated from the cDNA of KO mice; indeed, if a 
promoter region, such as a TATA box and/or GCp islands, were to exist upstream of 
exon 20, a PCR product may then be generated in both KO and WT mice. Finally, a 
positive control for both WT and KO cDNA amplified the cDNA for Dystrophin exons 8 
to 10. Dystrophin is encoded by 79 exons and its loss of function is responsible for 
Duchenne Muscular Dystrophy (DMD) (Roberts et al., 1993). Figures 11 and 12 show 
the gel electrophoresis of the PCR amplifications from the quadriceps of KO and WT 
mice in the presence and absence of dimethyl sulfoxide (DMSO) respectively. 
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  Forward Primer Reverse Primer Length WT KO 
Reaction 4-10 Fam65b-exon 4 Fam65b-Exon 10/1 380 bp + - 
Reaction 6-10 Fam65b-exon 6 Fam65b-Exon 10/2 380 bp + - 
Reaction 20-23 Fam65b- exon 20 Fam65b-exon 23 334 bp + +/- 
Reaction 8-10 Dystrophin- exon 8 Dystrophin-exon 10 349 bp + + 
 
Table 2. RT-PCR reaction conditions for transcriptional analysis of WT and Fam65b-/- 
mice. A list of the primers utilized for each specific RT-PCR reaction and the size of the expected 
amplicons is provided. The genetic mouse background where we expect to observe specific PCR 
products is also reported. 
 
 
Figure 11. RT-PCR Reactions of WT and KO with DMSO. Reactions 4-10 and 6-10 which are 
summarized in Table 2, were run in the presence of 0.16% vol. of DMSO. The 100bp ladder 
shows markers from 1.5 Kb to 0.1 Kb. 
 
 
 
 
100bp 
ladder 
H2O H2O H2O H2O 100bp 
ladder 
WT WT WT WT KO KO KO KO 
Fam65B exon 4- 10 Fam65B exon 6- 10 Fam65B exon 20- 23 Dystrophin exon 8- 10 
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Figure 12. RT-PCR Reactions of WT and KO without DMSO. Reactions 4-10 and 6-10, which 
are summarized in Table 2, were run in the absence of DMSO. The 100bp ladder shows markers 
from 1.5 Kb to 0.1 Kb. 
 
As predicted, reactions 4-10 and 6-10 are only observed in cDNA of WT mice, 
both in the presence and absence of DMSO. Nevertheless, it should be noted that a non-
specific band of about 1.4 Kb is present in the WT lane of reactions 4-10 and 6-10 
(Figures 11 and 12). 
As aforementioned, reaction 20-23 amplifies a region from exon 20 to 23 of the 
Fam65b gene which is located downstream of the deleted region. If a single promoter 
region is expected to exist upstream of the transcription start site of the Fam65b gene, the 
product of this reaction would only be amplified from the cDNA of WT mice. 
Nevertheless, as the expected amplicon (334bp) for this reaction is observed both in the 
KO and WT lanes, the presence of a putative transcription start site downstream of the 
deleted region and upstream of exon 20 cannot be excluded. Consequently, an online 
promoter-scan program was used to identify potential transcriptional promoter regions 
100bp 
ladder 
H2O H2O H2O H2O 100bp 
ladder 
WT WT WT WT KO KO KO KO 
Fam65B exon 4- 10 Fam65B exon 6- 10 Fam65B exon 20- 23 Dystrophin exon 8- 10 
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downstream of the Fam65B deletion cassette (“Promoter 2.0 Prediction Server,” n.d.); 
four entries were found, respectively within intron 15, 16, 17 and 19 of the Fam65b gene. 
If this explanation were to be true, we cannot exclude the possibility that shorter Fam65b 
isoforms may also be translated and could possibly be identified as protein-coding 
transcripts by WB analysis. Table 3 shows the location of these putative promoter sites 
and the sizes of the corresponding encoded proteins. 
 
Highly Likely Promoters 
Downstream of Deletion 
Cassette 
Genomic Location Putative Protein Size 
1 24,801,658 (intron 15) 340 AA (~37.4 Kd) 
2 24,804,358 (intron 16) 284 AA (~31.2Kd) 
3 24,806,758 (intron 17) 236 AA (~25.9 Kd) 
4 24,810,858 (intron 19) 131 AA (~14.4 Kd) 
 
Table 3. Promoter locations downstream of Fam65B deletion cassette. The genomic location 
of putative promoter regions downstream of the Fam65B deletion cassette and the expected size 
for the putative proteins are listed. 
 
Finally, as explained above, amplification of a region of the dystrophin cDNA, 
was conducted as positive control for both WT and KO mice. Indeed, both in the 
presence and absence of DMSO, this amplicon is transcribed both in KO and WT mouse 
quadriceps.  
Analysis of Fam65B protein expression 
WB studies were conducted on lysates prepared from both fully differentiated 
skeletal muscle tissues and cultured myoblasts undergoing differentiation. As previous 
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studies have shown that Fam65B expression in primary human fetal myoblasts reaches its 
maximum 24 to 48 hours after switching them into differentiation medium, cells were 
approximately harvested at these time points (Yoon et al., 2007; Balasubramanian et al., 
2014). Protein lysates harvested from differentiating human myoblasts were used as a 
positive control. The lysate of human myoblasts showed two major bands (~ 70 Kd and 
~110 Kd), while several bands were identified on the lysates isolated from Fam65B-/- 
and WT mice. To identify the best conditions for the WB analysis of murine lysates, 
different combinations of primary antibody (Ab) and blocking solutions were utilized.  
Table 4 summarizes the different conditions tested. 
 
  Blocking Solution  Primary Ab  
Figure 13a 3% BSA Mouse Monoclonal MO1 (1:1000)  
Figure 13b 3% BSA Rabbit Monoclonal GAPDH (1:5000) 
Figures 14a & 14b 5% BSA + 1%  NFDM Rabbit Polyclonal Custom Made (1:1000) 
Figure 15 5% BSA + 1%  NFDM  Mouse Monoclonal MO1 (1:1000) 
 
Table 4. Summary of western blots experimental condition. A list of the primary antibodies 
and blocking solutions used for each WB is provided. Secondary antibodies were chosen against 
the species in which the primary antibodies were raised. NFDM= non fat dry milk; BSA= bovine 
serum albumin. 
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Figure 13. Fam65b expression analysis in murine skeletal muscle tissue lysates with MO1 
Ab. Lanes labeled as WT and 2681 KO are lysates isolated from quadriceps of two mice. Lanes 
labeled as 12 Hr and 24 Hr correspond to lysates harvested from primary human fetal myoblasts. 
a) Mouse monoclonal antibody (MO1) raised against the full length of Fam65B was used as 
primary Ab (1:1000) in blocking solution. b) Rabbit monoclonal antibody raised against GAPDH 
was used as primary Ab (1:5000) in blocking solution.  
 
It should be noted that though bands of ~200 Kd, ~ 100 Kd and ~ 25 Kd present 
in lane KO 2681 (Fam65b -/-) decreased in intensity relative to the WT lane, none of the 
band disappeared (see Figure 13a). Furthermore, while the ~100 Kd band may 
correspond to the Fam65 protein, it is more likely that the ~ 200 Kd band represents 
either a dimeric form of Fam65b or a cross-reacting protein. In order to compare Fam65b 
protein sequence to the ones of other proteins and see whether they share significant 
homology, an online database, called Basic Local Alignment Search Tool (BLAST) was 
utilized (“NCBI Blast: Protein Sequence (1078 letters),” n.d.). The search showed that 
dysferlin, a cell membrane protein whose function is critical for maintance of 
plasmalemma integrity and for regeneration of skeletal muscle, shares 28% homology 
with Fam65b (Han et al., 2011). Furthermore, previous studies in our lab have shown that 
Fam65b co-immunoprecipitates with dysferlin (Balasubramanian et al., 2014). For these 
250Kd 
130Kd 
100Kd 
70Kd 
55Kd 
35Kd 
25Kd 
15Kd 
250Kd 
130Kd 
100Kd 
70Kd 
55Kd 
35Kd 
25Kd 
15Kd 
WT  2681 KO  12 Hr 24 Hr 
b) a) 
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reasons, the potentially cross-reacting band with a molecular weight of ~ 200 Kd may be 
dysferlin. Instead, the ~ 25 Kd band may represent a short isoform of Fam65b due to the 
presence of an alternative promoter downstream of the deleted area, located in intron 17 
of the Fam65b gene (see Table 3). Furthermore, because the primary Ab (MO1) was 
raised in mouse, and the tissue lysates are also murine in origin, MO1 can cross-react 
with light (25 Kd) and heavy chains (50 Kd) of IgGs present in murine lysates. Therefore, 
for studying Fam65b protein expression in mouse tissue, a custom-made Ab raised in 
rabbit was also utilized. 
 
          
Figure 14. Fam65b expression analysis in murine skeletal muscle tissue lysates with 
custom made Ab. Lanes labeled as WT and KO are lysates isolated from murine quadriceps. 
Lanes labeled as 12 Hr and 24 Hr correspond to lysates harvested from differentiating primary 
human fetal myoblasts. a and b) Rabbit Polyclonal Custom made antibody raised against a 
peptide of Fam65B was used as primary Ab (1:1000) in blocking solution. Both experiments were 
performed by following the same protocol, yet lysates extracted from additional mice were 
analyzed in b. 
As in previous WBs potentially cross-reacting bands were observed, in the WBs 
illustrated in figure 14a and 14b, the concentration of BSA was increased to 5% and 1% 
of non-fat dry milk (NFDM) was also added. Figure 14a shows that the bands of 200 Kd, 
   a) b) 
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100 Kd and 25 Kd detected in the WT lysate are of greater intensity relative to those 
detected in the KO lysate. Nevertheless, this result could not be reproduced in Figure 
14b. Indeed, only the expression of the band at 25 Kd is reduced in tissue lysates of KO 
mice relative to those of WT mice. Instead, none of the other bands disappeared in the 
lanes of KO tissue lysates. For this reason, as it is known that lysates of myogenic cells 
cultured in vitro are more enriched for Fam65b than lysates that have been directly 
prepared from differentiated skeletal muscles, myogenic cells were isolated from both 
KO and WT mice via FACS as described in the methods section. Cells were cultured and 
induced to differentiate before being harvested either 36 or 48 hours after switching them 
into differentiation medium.  
 
   
Figure 15. Fam65b expression analysis in lysates of murine myoblast with MO1 Ab. Lanes 
labeled as WT4, WT5, KO4 and KO5 are lysates isolated from murine myoblast, 48 hours after 
differentiation had been induced. Lanes labeled as undifferentiated and 24 Hr humans 
correspond to lysates harvested from primary human fetal myoblasts before and after 
differentiation. a) Mouse monoclonal antibody (MO1) raised against the full length of Fam65B 
was used as primary Ab (1:1000). 
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Figure 15 shows that bands of ~ 200 Kd and ~ 55 Kd are equally expressed in 
lysates harvested from both WT and KO differentiating murine myoblasts. Yet, the band 
of ~ 120 Kd, which may correspond to the longest Fam65b isoform, is only present in 
WT 5 (murine myoblasts 48 hours post differentiation) and human fetal myoblasts lanes; 
this ~ 120 Kd is absent in WT 4, KO4 and KO5 (murine myoblasts 48 hours post 
differentiation respectively isolated from WT and Fam65b-/- mice). This result may be 
encouraging, but it remains important to answer why the WT4 lane lacks this 120Kd 
band. A worthwhile experiment would be to re-genotype and conduct RT-PCR analysis 
for the WT4 clone to fully ensure that it was not misgenotyped at the beginning of this 
study. 
Fam65B and its potential role in adiposity 
To completely characterize Fam65b-/- mice and observe any relevant phenotypic 
changes, the weight of both KO and WT animals were recorded monthly over the course 
of 15 months. It should be noted that the weights of Fam65b-/- male and female mice are 
significantly greater than those of their WT counterparts (Figure 16). The difference in 
weight between WT and KO mice remains significant for a longer period of time in the 
male gender, where the KO background is significantly heavier up to 12 months of age (p 
value < 0.05). Instead, in females, though Fam65b-/- animals are remarkably heavier up 
to 7 months of age (p value 0.01), statistical significance is lost after this time point.  
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Figure 16. Fam65-/- and WT mice weight chart. The weight of Fam65 -/- KO and WT were 
recorded over a period of 15 months. 
 
As this significant difference in weight between WT and KO backgrounds has 
been recorded, it is plausible to think that the loss of Fam65b expression may be 
responsible for the observed phenotype. For this reason, it would be interesting to utilize 
new cohorts of Fam65b-/- and WT mice in weight studies.   
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DISCUSSION 
 
The present work investigates the functionality of the Fam65b KO mouse model 
at the gene, transcript and protein levels, with the aim to better comprehend the role of 
this protein during the differentiation of myogenic cells. Because it is thought that 
Fam65b plays an important role in facilitating myoblast fusion and myotubes formation, 
which are critical steps of myogenic differentiation, the availability of a Fam65b KO 
model would allow us to show whether the lack of expression of this protein 
compromises proper skeletal muscle development and regeneration. Furthermore, the 
generation of a functional Fam65b KO mouse model would enable our lab to temporally 
define the expression of Fam65b relative to other MRFs, such as MRF4 and myocyte 
enhancer factor 2C (MEF2C), and to understand whether the ablation of Fam65b also 
affects the ability to express these other myogenic proteins.  
In this work, PCR analysis of 12 Fam65b KO mice has showed that partial 
deletion of the Fam65B gene was performed successfully by inserting a deletion cassette 
via homologous recombination between exon 2 and exon 14 (see Figures 7-10). 
Furthermore, RT-PCR analysis showed that the transcript corresponding to the deleted 
region of the Fam65b gene is not transcribed in KO mice (see Figures 11-12). Since these 
results show that Fam65b KO mice lack the genomic region between exon 2 and exon 14 
of Fam65b, and that they do not transcribe the mRNA corresponding to this specific 
genomic region, it was initially thought that a true KO model had been generated. 
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Nevertheless, Figures 11 and 12 also show that Fam65b-/- mice transcribe a 
mRNA region (exon 20 to exon 23) which is downstream of the deletion cassette. This 
finding could be explained by the presence of a putative transcription start site 
downstream of the deleted region and upstream of exon 20. Indeed, analysis via a 
promoter-scan program revealed the presence of four putative transcription start sites 
downstream of the deletion cassette (see Table 3). The presence of a promoter within 
intron 17 would potentially result in the expression of a Fam65B truncated isoform of 
25.9 Kd. Because a band of approximately this molecular weight is also detected via WB 
analysis (see Figures 13a, 14a and 14b), this finding further suggests that the presence of 
additional promoter regions downstream of the deletion cassette may indeed exist. 
Although initial genomic and transcriptional analysis of this KO model revealed 
promising results, experiments studying Fam65b expression in KO mice have been more 
problematic. Because previous WB analysis of human fetal myoblast performed by Yoon 
et al. (2007) showed that the two major isoforms of Fam65B in muscle tissue were 
105Kd and 70Kd, molecular bands of approximately these sizes were expected to be 
present in muscle lysates of WT mice, and to be absent in Fam65b -/- mice. Nevertheless, 
bands of 200Kd, 120 Kd, 55 Kd and 25 Kd were identified in protein lysates of skeletal 
muscle tissues of both WT and KO mice (see Figures 13a, 14a and 14b). Although the 
expression of these isoforms was decreased in KO mice compared to WT ones (see 
Figures 13a and 14a), none of the bands were absent in KO samples when protein 
extraction was directly performed in skeletal muscle tissue. Because Fam65b shares 28% 
homology with dysferlin (which has a molecular weight of ~ 200 Kd), and given the fact 
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that these two proteins also co-immunoprecipitate, the 200 Kd band may correspond to 
dysferlin (Balasubramanian et al., 2014; “NCBI Blast: Protein Sequence (1078 letters),” 
n.d.). This hypothesis implies that dysferlin is cross-reacting with the Fam65b antibody, 
and that the immunogenic site is being shared by the two proteins. Furthermore, since 
both the MO1 Ab and the custom-made Ab were previously generated to recognize the 
human Fam65b protein, it is possible that some of the bands identified in murine skeletal 
muscle lysates are cross-reacting bands.  
Consequently, with the objective of minimizing cross-reacting bands, two 
strategies were undertaken: the concentration of blocking solution was increased to 5% 
BSA and 1% NFDM, and myogenic cells - which are more enriched for the Fam65b 
protein - were isolated from both KO and WT mice via FACS. Under these conditions, 
although the 55 Kd and 200 Kd bands were present in both KO and WT samples, the 120 
Kd band, which may correspond to the long isoform of Fam65b, was only present in WT 
5 clone muscle cells and absent in the KOs (see Figure 15). Nevertheless, as Figure 15 
also shows that the WT 4 clone lacks the 120 Kd band, it would be important to conduct 
once more PCR and RT-PCR analysis to ensure that this clone was not initially 
misgenotyped.  
Moreover, to further improve the accuracy of our experiments, additional 
strategies could be employed. The use of protein G magnetic beads to pre-clear IgG light 
and heavy chains would enable us to still utilize the mouse-raised MO1 Ab in whole 
murine skeletal muscle lysates and reduce the presence of cross-reacting bands. This step 
could also be performed for myogenic cells isolated by FACS; yet it is well known that 
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the amount of IgGs is significantly lower in purified cell lines than in whole skeletal 
muscle tissue. Furthermore, since the commercially available Abs and our custom-made 
Ab have all been designed to detect the human Fam65b protein, it would be worthwhile 
to design a new Ab that specifically recognizes an epitope of the murine Fam65b protein.  
Finally, if further WBs of protein lysates of either differentiated skeletal muscles 
or myogenic cells from Fam65b-/- were insufficient to fully demonstrate the validity of 
this knock-out strategy, another technique should be employed to generate a functional 
KO model. A valid alternative may be to use the Clustered Regularly Interspaced Short 
Palindromic Repeats (CRISPR) Cas9 technology. The enzyme Cas9 is a bacterial 
nuclease directed by a single guide RNA (sgRNA) sequence that specifically base-pairs 
with a 20-bp DNA target; an additional requirement for the selection of Cas9 target loci 
is the presence of a protospacer adjacent motif (PAM) sequence which is located 3’ of the 
20-bp target sequence (F. A. Ran et al., 2013; Hsu, Lander, & Zhang, 2014). Upon 
complementary binding of the guide RNA to the target DNA, the Cas9 induces genome 
editing by introducing double-stranded breaks (DSB) in the target region. The DNA 
cleavage promotes one of two possible damage repair mechanisms: the error prone non 
homologous end joining (NHEJ), which can be utilized to mediate gene knockouts, or the 
high fidelity homologous directed repair (HDR), which introduces precise modifications 
when an exogenous repair template is also being supplied. NHEJ, by generating DSB 
within a coding exon, can induce frameshift mutations and premature stop codons (Cong 
et al., 2013). Furthermore, to increase the specificity of the NHEJ pathway and minimize 
off-target activity, a double nicking strategy can be used to introduce DSBs ; indeed, 
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while the WT Cas9 nuclease is guided by an sgRNA, the D10A mutant Cas9 nickase 
(Cas9n) is directed by two appropriately oriented sgRNAs to promote the formation of 
single-stranded nicks on both target DNA strands (F. A. Ran et al., 2013; H. Yang, Wang, 
& Jaenisch, 2014). As single-stranded nicks are repaired without indel formation, DSBs 
can only occur if both sgRNAs are able to locate target sequences within a defined space. 
Thus, this strategy, by doubling the number of bases that need to be recognized at the 
target site, significantly increases the specificity of genome editing. As our aim is to 
ablate the expression of Fam65b, the induction of NHEJ would allow us to generate a 
functional KO and better assess how this protein contributes to the differentiation of 
myogenic cells. A possible experimental strategy would be to transfect C2C12 cells with 
an expression plasmid bearing the oligo pairs encoding for both a Fam65b-specific 
sgRNA scaffold backbone and Cas9. Finally, after testing the efficacy of the targeted 
cleavage via the SURVEYOR nuclease assay or sequencing analysis, transfected cells 
can be clonally expanded to create isogenic cell lines with the specific mutation. A 
scheme of this editing strategy is shown in Figure 17.  
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Figure 17. Model of CRISPR Cas9 editing strategy.  sgRNA and Cas9 sequences are first 
cloned into an expression vector. The pSpCas9 plasmid in then transfected into cells, and the 
targeted DNA modifications are detected via sequencing. Cell clones bearing the desired 
mutation are isolated via FACS, and finally expanded to generate isogenic cell lines. Adapted 
from Ran et al. (2013). 
 
Alternatively, the CRISPR/Cas9 system could be employed to generate a Fam65b 
KO mouse model. This technology has been employed to introduce loxP sites into 
specific exon regions, so that CRE recombinase-mediated excision can then be performed 
to delete the genomic area of interest (H. Yang et al., 2013, 2014). This strategy requires 
creation of a vector donor which bears oligo nucleotide sequences corresponding to the 
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loxP sites, in addition to those encoding for both a Fam65b-specific sgRNA scaffold 
backbone and Cas9. The plasmid construct would be introduced into the cytoplasm of a 
mouse zygote, which is then transferred into the oviduct of a pseudopregnant mouse. This 
method has been successfully employed to generate mutant mice and rats models for 
Duchenne Muscular Dystrophy, and we think it may help to understand how the lack of 
function in Fam65b affects the differentiation of myogenic cells in vitro and in vivo 
(Nakamura et al., 2014).  
As previously explained, studies have shown that the downregulation of Fam65b 
via RNAi does not affect MyoD expression levels, while resulting in a significant 
reduction of myogenin expression (Yoon et al., 2007). These results suggest that Fam65b 
acts downstream of MyoD, yet upstream of myogenin in the differentiation of 
mononuclear myogenic cells. The availability of a functional Fam65b KO murine cell 
line or mouse model would allow us to define the temporal expression of this protein 
relative to other myogenic transcriptional regulators like MRF4 and MEF2C. Previous 
studies have reported that MRF4 KO mice, while possessing a wide range of phenotypic 
variance in muscle development, show augmented myogenin expression; this 
experimental outcome has led to the belief that MRF4 may act in parallel to myogenin, 
and has a role in terminal differentiation similar to myogenin (Patapoutian et al., 1995; 
Francetic & Li, 2011). We hypothesize that ablation of Fam65b expression may result, as 
it occurs with myogenin, in the reduction of MRF4 expression levels. Instead, MEF2C 
has a more longitudinal expression span during myogenic differentiation (Panda et al., 
2014). Indeed, chromatin immuno-precipitation (ChIP) experiments have revealed that 
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MyoD upregulates the transcription of MEF2C by binding to an A/T rich enhancer 
regions during early skeletal muscle differentiation (Dodou, Xu, & Black, 2003; Potthoff 
et al., 2007); at the same time, MEF2C, by binding to promoter regions of MRF4 and 
myogenin, amplifies and maintains their expression, thus contributing to the later stages 
of myotube development (Buchberger, Ragge, & Arnold, 1994; Naidu, Ludolph, To, 
Hinterberger, & Konieczny, 1995). Consequently, in order to understand at which stage 
of skeletal myogenesis we can place Fam65B expression relative to other myogenic 
regulatory factors like MyoD, MRF4, myogenin and MEF2C, differentiating myoblasts 
from both KO and WT Fam65b mice should be harvested at different time points, and 
WB analysis of Fam65B and these other MRFs should be performed. Furthermore, to 
establish whether the transcriptional activity of Fam65b is controlled by key myogenic 
transcription factors like MyoD or Myf5, which are responsible for the initiation of 
myogenic differentiation, ChIP analysis may also be carried out.  
Previous studies from our lab have also shown that Fam65b, by directly 
interacting with HDAC6, may play a role in regulating microtubule dynamics 
(Balasubramanian et al., 2014); it now remains to be elucidated whether this function 
may contribute to the migration of individual myoblasts toward one another, thus 
facilitating myotube formation and the progress of myogenic differentiation. It is known 
that HDAC6, by modulating the levels of acetylation of α-tubulin and cortactin, is 
important for the regulation of cell motility (J. Ran et al., 2015). 
In Hela cells, cortactin, a protein which interacts with f-actin at the leading edge 
of migrating cells to form lamellipodia and membrane ruffles, is a target of HDAC6. 
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Utilization of HDAC inhibitors or HDAC6 siRNA resulted in cortactin hyperacetylation 
and inhibition of its translocation to the cell periphery; this prevented cortactin from 
associating with F-actin, and thus impaired cell motility (X. Zhang et al., 2007). Thus, it 
would be interesting to study, by either co-immunoprecipitation or the proximity ligation 
assay (PLA), whether Fam65B interacts with cortactin and F-actin, and whether Fam65b 
protein contributes to regulate cortactin acetylation levels in differentiating myoblasts.  
Moreover, it should be pointed out that cortactin translocation to the cell 
periphery is mediated by the small GTPase Rac1; at this location, cortactin has been 
shown to promote the activation of the actin-nucleating complex Arp2/3 and facilitate the 
formation of lamellipodia networks (Weed et al., 2000; Uruno et al., 2001; Weaver et al., 
2001; Head et al., 2003). It is also known that the Rho family of guanine nucleotide 
exchange factors (GEFs) is involved in cytoskeletal rearrangement, formation of focal 
adhesion, and regulation of cell polarity. As Fam65B shares 30% homology with the 
GTPase Rac1 (NCBI, Aceview), it may, in conjunction with Rac1, regulate the activity of 
cortactin within the cell. These experiments would allow us to understand more precisely 
the role of Fam65B in the migration of myoblasts, and whether this function contributes 
to differentiation. 
Finally, as our data indicate that Fam65KO mice are significantly heavier than 
WT mice, and that this phenotype is consistently observed across both genders during the 
first seven months of age, it would be interesting to investigate whether Fam65b plays a 
regulatory role in fat metabolism. For example, since the important role of the 
mammalian target of rapamycin (mTOR) signaling pathway as a regulator of adipose 
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tissue mass is well established, the expression levels of mTOR and its downstream 
effector AKT, also known as protein kinase B (PKB), may be analyzed in both WT and 
KO mice (Laplante & Sabatini, 2009; Blanchard et al., 2012).   
Furthermore, it is noteworthy that cytoskeletal modifications and microtubule 
rearrangements are important for the differentiation of pre-adipocyte into mature 
adipocytes (Kanzaki & Pessin, 2002; Takenouchi et al., 2004). Importantly, the levels of 
acetylated α-tubulin are significantly increased during cellular adipogenesis, and the 
acetylation state of this protein is regulated by acetyltransferase MEC-17 and HDAC6 
(W. Yang et al., 2013). Furthermore, C57BL/6 mice fed on a high fat diet revealed 
elevated levels of acetylated α-tubulin and MEC-17; additionally, knock-down of 
HDAC6 in fibroblasts (3T3-L1 cells) leads to both elevated acetylated α-tubulin and 
increased content of lipid droplets (W. Yang et al., 2013). Furthermore, it has been 
reported (unpublished data) that HDAC6 KO mice gain significantly more weight than 
WT mice, and that cells lacking HDAC6 increase glucose uptake while downregulating 
fatty acid oxidation (Kapur, 2015). As Balasubramanian et al. (2014) showed that 
downregulation of Fam65b induced a reduction in the translated levels of HDAC6, this 
negative-feedback response may result in increased levels of acetylated α-tubulin and 
differentiated adipocytes, thus potentially explaining the phenotype that we observed in 
Fam65KO mice.  
Other studies have also shown that down-regulation of HDAC6 results in the 
hyperacetylation and destabilization of the chaperone heat shock protein 90 (Hsp90) 
(Kovacs et al., 2005). Because Hsp90 needs to be in its deacetylated state to bind and 
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generate a stable complex with the glucocorticoid receptor (GR), downregulation of 
HDAC6 indirectly compromises the stability of GR, which becomes defective in ligand 
binding and transcriptional activation (Kovacs et al., 2005) . It is well known that proper 
function of the GR is critical for maintaining metabolic homeostasis (Rose, Vegiopoulos, 
& Herzig, 2010); therefore, it would be interesting to investigate whether Fam65b, by 
regulating the levels of  HDAC6, can regulate the acetylation levels of tubulin and 
Hsp90, and thus play a critical role in the body energy balance. 
This series of experimental questions will allow us to better define the role of 
Fam65b in both myogenic differentiation and cellular metabolism; for this reason, we 
believe that the characterization of the KO mouse model described in this thesis will 
enable us to design additional experiments. The present studies represent an important 
step towards future accomplishments in this line of research. Furthermore, it is important 
to point out that no previous studies have so far characterized a Fam65b KO mouse 
model in the context of skeletal muscle differentiation. Only Gao et al. (2015), who 
analyzed the function of Fam65b in the polarization of neutrophils, reported to have 
investigated the motility of neutrophils isolated from Fam65b KO mice, and that those 
immune cells exhibited defective directionality in their chemotaxis patterns. 
Nevertheless, the characterization of their Fam65b KO mouse model at the gene, 
transcript and protein levels was not reported. Consequently, as the complete 
characterization of a Fam65b KO model has yet to be described in the literature, the 
importance of the work undertaken in this thesis is significant. We here report that a 
Fam65b KO mouse model was generated by replacing the genomic region of Fam65b 
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spanning exon 2 to exon 14 with a deletion cassette. Although genomic and 
transcriptional studies have shown that a KO mouse model may have been generated, 
WB analysis of Fam65b expression remains inconclusive. Indeed, while lysates of 
murine myoblast isolated from KO clones lack the 120 Kd isoform of Fam65b, WBs of 
murine skeletal muscle tissue lysates can still detect the presence of the main Fam65b 
isoforms. Furthermore, the present study, by reporting that Fam65b KO mice are 
significantly heavier than WT mice and that this phenotype is observed in both genders 
during the first seven months of age, highlights a potential link between the loss of 
Fam65b expression and weight gain. Finally, as a definitive conclusion about the 
functionality of the generated KO mouse model cannot still be made, further work is 
required to answer these questions and additional steps will be taken to generate a new 
KO model via the CRISPR-Cas9 technology. 
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